详情页 - 河北医科大学第四医院机构库

当前位置：首页 > 详情页

Unveiling prognosis and traits of dMMR/MSI-H gastric and colorectal cancer after curative surgery: A large-scale, multi-center, retrospective study in China

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：

机构： [1]Tianjin Med Univ Canc Inst & Hosp, Dept Gastrointestinal Med Oncol, Tianjin, Peoples R China [2]Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China [3]Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China [4]Wuhan Univ, Dept Gastrointestinal Surg, Zhongnan Hosp, Wuhan, Peoples R China [5]Wuhan Univ, Zhongnan Hosp, Dept Gastr & Colorectal Surg Oncol, Wuhan, Peoples R China [6]Harbin Med Univ, Affiliated Hosp 4, Harbin, Heilongjiang, Peoples R China [7]Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China [8]Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China [9]Hebei Med Univ, Hosp 4, Dept Surg 3, Shijiazhuang, Peoples R China [10]Xiamen Univ, Affiliated Hosp 1, Xiamen, Fujian, Peoples R China [11]Qilu Hosp Shandong Prov, Jinan, Peoples R China [12]Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China [13]Nanjing Univ, Drum Tower Hosp, Dept Gen Surg, Med Sch, Nanjing, Peoples R China [14]Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China [15]Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China [16]Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China [17]Wannan Med Coll, Affiliated Hosp 1, Wuhu, Anhui, Peoples R China [18]Sichuan Prov Canc Hosp Inst, Chengdu, Sichuan, Peoples R China [19]Zhejiang Univ, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China [20]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China [21]Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China

出处：

DOI：

ISSN：

关键词： 3282-206-2713-2693 283-237-255 613-135-2370-7650-2700 283-11574 3282-206-2497-2540-2595 613-135-2370-7650-2454 613-213-2711-3371 5 4 3 2 38092-20390

语种：

WOS：

中科院分区：

出版当年[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2024]版：

无

最新[2023]版：

Q1 ONCOLOGY

影响因子： 42.1 最新[2023版] 37.4 最新五年平均 42.1 出版当年[2024版] 37.4 出版当年五年平均 42.1 出版前一年[2023版]

第一作者：

第一作者机构： [2]Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer [2]Phase II clinical study evaluating the efficacy and safety of disitamab vedotin combined with sintilimab and S-1 in the conversion treatment of HER2-overexpression unresectable gastric cancer [3]CTLA-4 blockade combined with 5-aza-2 '-deoxycytidine enhances the killing effect of MAGE-A family common antigen peptide-specific cytotoxic T cells on breast cancer [4]VEGF-C及其受体VEGFR-2/3与肺癌关系的研究进展 [5]MRI对于乳腺X线摄影BI-RADS 4～5类微钙化病变的诊断价值 [6]SHP-2-induced M2 polarization of tumor associated macrophages via IL-4 regulate colorectal cancer progression [7]MAGE-A9和MAGE-A11基因在乳腺癌组织中的表达及其临床意义 [8]家族性帕金森病α-共核蛋白基因第3、4外显子的初步研究 [9]VEGF-D及其受体Flt-4在胰腺癌中的表达及意义 [10]尼美舒利抑制肺腺癌细胞增殖机制研究